APTARGROUP, INC. ATR

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $131.97
Market Cap $8.46B
P/E Ratio 22.41
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.4% YoY
$3.78B
3-Yr CAGR: 4.4%
Net Income ↑4.9% YoY
$392.79M
Net Margin: 10.4%
Free Cash Flow ↓-18.4% YoY
$299.58M
FCF Yield: 3.54%
EPS (Diluted) ↑6.5% YoY
$5.89
Basic: $5.97
Return on Equity Efficiency
14.7%
ROA: 275.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ATR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $2,330.9M $687.4M $205.6M $3.17 $327.2M $198.2M
FY 2017 $2,469.3M +5.9% $722.3M $220.0M +7.0% $3.41 +7.6% $324.7M $168.1M -15.2%
FY 2018 $2,764.8M +12.0% $795.5M $194.7M -11.5% $3.00 -12.0% $313.6M $102.4M -39.1%
FY 2019 $2,859.7M +3.4% $874.4M $242.2M +24.4% $3.66 +22.0% $514.5M $272.2M +165.9%
FY 2020 $2,929.3M +2.4% $906.0M $214.0M -11.6% $3.21 -12.3% $570.2M $324.2M +19.1%
FY 2021 $3,227.2M +10.2% $347.3M $244.1M +14.0% $3.61 +12.5% $363.4M $55.5M -82.9%
FY 2022 $3,322.2M +2.9% $379.3M $239.3M -2.0% $3.59 -0.6% $478.6M $168.2M +203.0%
FY 2023 $3,487.4M +5.0% $404.0M $284.5M +18.9% $4.25 +18.4% $575.2M $262.9M +56.3%
FY 2024 $3,582.9M +2.7% $496.5M $374.5M +31.7% $5.53 +30.1% $643.4M $366.9M +39.6%
FY 2025 $3,777.2M +5.4% $1,404.7M $392.8M +4.9% $5.89 +6.5% $570.0M $299.6M -18.4%
$

Valuation

Market Price $131.97
Market Cap $8.46B
Enterprise Value N/A
P/E Ratio 22.41
P/B Ratio 3.16
FCF Yield 3.54%
Dividend Yield 1.39%
Shares Outstanding 63,820,300
%

Profitability & Margins

Gross Margin 37.19%
Operating Margin 13.26%
Net Margin 10.40%
Return on Equity (ROE) 14.72%
Return on Assets (ROA) 275.92%
Asset Turnover 26.53x
Revenue 3-Yr CAGR 4.37%
🛡️

Financial Health & Liquidity

Current Ratio 0.12
Cash Ratio 0.35
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $402.42M
Total Debt N/A
Book Value / Share $41.81
💧

Cash Flow Efficiency

Operating Cash Flow $570.00M
Capital Expenditures (CapEx) $270.42M
Free Cash Flow $299.58M
OCF / Revenue 15.09%
FCF / Revenue 7.93%
FCF 3-Yr CAGR 21.22%
🏷️

Per Share Metrics

EPS (Diluted) $5.89
EPS (Basic) $5.97
Dividends / Share $1.83
Book Value / Share $41.81
EPS YoY Growth 6.51%
🏛️

Balance Sheet (FY 2025)

Total Assets $142.35M
Total Liabilities $1.17B
Stockholders' Equity $2.67B
Current Assets $142.35M
Current Liabilities $1.17B